The Evolving Understanding of IgA Nephropathy: Implications of New Treatment for Managed Care Pharmacy Professionals

In this webinar, expert faculty will discuss IgA nephropathy, pathophysiology, new and emerging therapies, and methods to address economic and disease burden in the managed care setting. Download the slides and review an expert commentary addressing key take-home messages from the live symposium.

Share

Program Content

Activities

IgA Nephropathy in Managed Care
The Evolving Understanding of IgA Nephropathy: Implications of New Treatment for Managed Care Pharmacy Professionals
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 02, 2023

Expires: November 01, 2024

Activities

IgA Nephropathy
The Evolving Understanding of IgA Nephropathy: Implications of New Treatment for Managed Care Pharmacy Professionals
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2023

Activities

IgAN and New Treatments
A Healthcare Professional’s Perspective on the Evolving Understanding of IgA Nephropathy and New Treatments
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 02, 2023

Expires: November 02, 2024

Faculty

cover img faculity

Michelle M. Richardson, PharmD, BCPS

Special and Scientific Staff
Tufts Medical Center
Assistant Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts

cover img faculity

Silvia Titan, MD, PhD

Senior Associate Consultant
Nephrology Division, Mayo Clinic
Rochester, Minnesota

Provided by

ProCE Banner

Provided by ProCE, LLC

Supporters

Supported by an educational grant from Calliditas Therapeutics.

Calliditas Therapeutics